Use of chromans
OwnerThomas Fahrig, Irene Gerlach +3inventors
InventorsThomas Fahrig, Irene Gerlach, Ervin Horvath, Reinhard Jork, Frank Mauler
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of 2-[4-({[(2R)-8-isopropoxy-chroman-2-yl]-methyl}amino)butyl]-1,2-benzisothiazol-3(2H)-one 1,1-dioxide, its physiologically acceptable salts, hydrates and/or solvates, in particular its hydrochloride, for the production of a medicament for the prophylaxis and/or treatment of Parkinson's disease.
Claims4
Use of 2-[4-({[(2R)-8-isopropoxy-chroman-2-yl]methyl}amino)butyl]-1,2-benzisothiazol-3(2H)-one 1,1-dioxide, its physiologically acceptable salts, hydrates and/or solvates for the production of a medicament for the prophylaxis and/or treatment of Parkinson's disease.
2-[4-({[(2R)-8-Isopropoxy-chroman-2-yl]methyl} amino)butyl]-1,2-benziso-thiazol-3(2H)-one 1,1-dioxide, its physiologically acceptable salts, hydrates and/or solvates for the prophylaxis and/or treatment of Parkinson's disease.
2-[4-({[(2R)-8-Isopropoxy-chroman-2-yl]methyl}amino)butyl]-1,2-benziso-thiazol-3(2h)-one 1,1-dioxide hydrochloride for the prophylaxis and/or treatment of parkinson's disease:
Dependencies are inferred from the claim text.